Collectively, these data suggest that HDM could accelerate lung tumor progression by activating the NLRP3/IL-1β signaling pathway and by creating a pro-tumor lung microenvironment rich in IL-1β+-macrophages, MDSCs, and PD-1+-myeloid cells. Here, IL1B is linked to neoplasm.